Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory L Smoot

Showing results (111-120 of 152) with videos related to

Pageof 16
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2025
Cause of death after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: a single center retrospective analysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Annals of Surgical Oncology|December 9, 2025
The Role of Primary Tumor Resection in Surgical Management of Asymptomatic Metastatic PNETs: A Retrospective Single-Center StudyVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Journal of Surgical Oncology|July 22, 2016
Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysisJohn R Bergquist, Tommy Ivanics, Curtis B Storlie, et al.
JHEP Reports : Innovation in Hepatology|March 23, 2023
Transcriptomic landscapes of effective and failed liver regeneration in humansPatrick Starlinger, Laura Brunnthaler, Chantal McCabe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 11, 2025
Long-term outcome of cytoreductive hepatectomy in metastatic neuroendocrine neoplasia G3: A single center retrospective analysisMarkus Ammann, Hallbera Gudmundsdottir, Stella K Adjei Antwi, et al.
FEBS Open Bio|September 19, 2024
YAP-TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escapeRoberto Alva-Ruiz, Ryan D Watkins, Jennifer L Tomlinson, et al.
Journal of Hepatology|March 8, 2024
Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinomaJennifer L Tomlinson, Binbin Li, Jingchun Yang, et al.
Annals of Surgery|April 5, 2019
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic CancerMark J Truty, Michael L Kendrick, David M Nagorney, et al.
Annals of Surgical Oncology|October 3, 2025
Carcinoid Syndrome Impacts Long-Term Outcomes After Hepatectomy for Small Bowel Neuroendocrine Tumor Liver MetastasisMarkus Ammann, Hallbera Gudmundsdottir, Elizabeth B Habermann, et al.
Cancers|February 11, 2023
Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United StatesAmro M Abdelrahman, Jun Yin, Roberto Alva-Ruiz, et al.
Pageof 16

Showing results (111-120 of 152) with videos related to

Sort By:
Pageof 16
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2025
Cause of death after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: a single center retrospective analysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Annals of Surgical Oncology|December 9, 2025
The Role of Primary Tumor Resection in Surgical Management of Asymptomatic Metastatic PNETs: A Retrospective Single-Center StudyVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Journal of Surgical Oncology|July 22, 2016
Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysisJohn R Bergquist, Tommy Ivanics, Curtis B Storlie, et al.
JHEP Reports : Innovation in Hepatology|March 23, 2023
Transcriptomic landscapes of effective and failed liver regeneration in humansPatrick Starlinger, Laura Brunnthaler, Chantal McCabe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 11, 2025
Long-term outcome of cytoreductive hepatectomy in metastatic neuroendocrine neoplasia G3: A single center retrospective analysisMarkus Ammann, Hallbera Gudmundsdottir, Stella K Adjei Antwi, et al.
FEBS Open Bio|September 19, 2024
YAP-TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escapeRoberto Alva-Ruiz, Ryan D Watkins, Jennifer L Tomlinson, et al.
Journal of Hepatology|March 8, 2024
Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinomaJennifer L Tomlinson, Binbin Li, Jingchun Yang, et al.
Annals of Surgery|April 5, 2019
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic CancerMark J Truty, Michael L Kendrick, David M Nagorney, et al.
Annals of Surgical Oncology|October 3, 2025
Carcinoid Syndrome Impacts Long-Term Outcomes After Hepatectomy for Small Bowel Neuroendocrine Tumor Liver MetastasisMarkus Ammann, Hallbera Gudmundsdottir, Elizabeth B Habermann, et al.
Cancers|February 11, 2023
Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United StatesAmro M Abdelrahman, Jun Yin, Roberto Alva-Ruiz, et al.
Pageof 16